Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser

Lennicke C, Rahn J, Bukur J, Hochgräfe F, Wessjohann LA, Lichtenfels R, Seliger B. Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid. Oncoimmunology. 2016 Dec 21;6(6):e1259049. doi: 10.1080/2162402X.2016.1259049. eCollection 2017.

 

Massa C, Robins H, Desmarais C, Riemann D, Fahldieck C, Fornara P, Seliger B. Identification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patients. Oncotarget. 2017 Feb 3. doi: 10.18632/oncotarget.15064. [Epub ahead of print]

 

Lennicke C, Rahn J, Kipp AP, Dojčinović BP, Müller AS, Wessjohann LA, Lichtenfels R, Seliger B. Individual effects of different selenocompounds on the hepatic proteome and energy metabolism of mice. Biochim Biophys Acta. 2017 Jan;1861(1 Pt A):3323-3334. doi 10.1016/j.bbagen.2016.08.015

 

Kaluđerović GN, Abbas M, Kautz HC, Wadaan MA, Lennicke C, Seliger B, Wessjohann LA. Methionine and seleno-methionine type peptide and peptoid building blocks synthesized by five-component five-center reactions. Chem Commun (Camb). 2017 Mar 17. doi: 10.1039/c7cc00399d. [Epub ahead of print]

 

Seliger B, Kloor M, Ferrone S. HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance. Oncoimmunology. 2017 Feb 6;6(2):e1171447. doi: 10.1080/2162402X.2016.1171447. eCollection 2017 Feb 6. Review.

 

 

Hendrickx W, Simeone I, Anjum S, Mokrab Y, Bertucci F, Finetti P, Curigliano G, Seliger B, Cerulo L, Tomei S, Delogu LG, Maccalli C, Wang E, Miller LD, Marincola FM, Ceccarelli M, Bedognetti D.Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.  Oncoimmunology. 2017 Feb 6;6(2):e1253654. doi: 10.1080/2162402X.2016.1253654. eCollection 2017 Feb 6.

 

Stroncek DF, Butterfield LH, Cannarile MA, Dhodapkar MV, Greten TF, Grivel JC, Kaufman DR, Kong HH, Korangy F, Lee PP, Marincola F, Rutella S, Siebert JC, Trinchieri G, Seliger B. Systematic evaluation of immune regulation and modulation. J Immunother Cancer. 2017 Mar 21;5:21. doi: 10.1186/s40425-017-0223-8. eCollection 2017 Mar 21. Review

 

Eichmüller SB, Osen W, Mandelboim O, Seliger B. Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape. J Natl Cancer Inst. 2017 Apr 5. doi: 10.1093/jnci/djx034. [Epub ahead of print]

 

Rahn J, Lennicke C, Kipp AP, Müller AS, Wessjohann LA, Lichtenfels R, Seliger B. Altered protein expression pattern in colon tissue of mice upon supplementation with distinct selenium compounds. Proteomics. 2017 Apr 14. doi: 10.1002/pmic.201600486. 

 

Quandt D, Fiedler E, Müller A, Marsch WC, Seliger B. High constitutive B7-H3 expression on human keratinocytes supports T cell immunity. J Dermatol Sci. 2017 Apr 11. pii: S0923-1811(16)30934-3. doi: 10.1016/j.jdermsci.2017.02.287.

 

Quandt D, Zucht HD, Amann A, Wulf-Goldenberg A, Borrebaeck C, Cannarile M, Lambrechts D, Oberacher H, Garrett J, Nayak T, Kazinski M, Massie C, Schwarzenbach H, Maio M, Prins R, Wendik B, Hockett R, Enderle D, Noerholm M, Hendriks H, Zwierzina H, Seliger B. Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget. 2017 Apr 24. doi: 10.18632/oncotarget.17397. [Epub ahead of print] Review.

 

Unverzagt S, Moldenhauer I, Nothacker M, Roßmeißl D, Hadjinicolaou AV, Peinemann F, Greco F, Seliger B. Immunotherapy for metastatic renal cell carcinoma. Cochrane Database Syst Rev. 2017 May 15;5:CD011673. doi: 10.1002/14651858.CD011673.pub2. Review. 

 

Donia M, Harbst K, Van Buuren M, Kvistborg P, Lindberg MF, Andersen R, Idorn M, Munir S, Ellebaek E, Mueller A, Fagone P, Nicoletti F, Libra M, Lauss M, Hadrup SR, Schmidt H, Andersen MH, Thor Straten P, Nilsson JA, Schumacher TN, Seliger B, Jönsson G, Svane IM. Acquired immune resistance follows complete tumor regression without loss of target antigens or IFN-γ signaling. Cancer Res. 2017 Jun 27. pii: canres.3172.2016. doi: 10.1158/0008-5472.CAN-16-3172. [Epub ahead of print]

 

Gulley JL, Berzofsky JA, Butler MO, Cesano A, Fox BA, Gnjatic S, Janetzki S, Kalavar S, Karanikas V, Khleif SN, Kirsch I, Lee PP, Maccalli C, Maecker H, Schlom J, Seliger B, Siebert J, Stroncek DF, Thurin M, Yuan J, Butterfield LH. Immunotherapy biomarkers 2016: overcoming the barriers. J Immunother Cancer. 2017 Mar 21;5(1):29. doi: 10.1186/s40425-017-0225-6.

 

Zhou F, Liu Y, Rohde C, Pauli C, Gerloff D, Köhn M, Misiak D, Bäumer N, Cui C, Göllner S, Oellerich T, Serve H, Garcia-Cuellar MP, Slany R, Maciejewski JP, Przychodzen B, Seliger B, Klein HU, Bartenhagen C, Berdel WE, Dugas M, Taketo MM, Farouq D, Schwartz S, Regev A, Hébert J, Sauvageau G, Pabst C, Hüttelmaier S, Müller-Tidow C. AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia. Nat Cell Biol. 2017 Jul;19(7):844-855. doi: 10.1038/ncb3563. Epub 2017 Jun 26.

 

Emens LA, Ascierto PA, Darcy PK, Demaria S, Eggermont AMM, Redmond WL, Seliger B, Marincola FM. Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape. Eur J Cancer. 2017 Jun 14;81:116-129. doi: 10.1016/j.ejca.2017.01.035. [Epub ahead of print] Review.

 

Seliger B. "Tumor immunology meets oncology (TIMO) XII", April 28th-30th 2016, Halle/Saale, Germany. 2017 Jul 10. doi: 10.1007/s00262-017-2037-4. [Epub ahead of print]

 

Feng Z, Bethmann D, Kappler M, Ballesteros-Merino C, Eckert A, Bell RB, Cheng A, Bui T, Leidner R, Urba WJ, Johnson K, Hoyt C, Bifulco CB, Bukur J, Wickenhauser C, Seliger B, Fox BA. Multiparametric immune profiling in HPV- oral squamous cell cancer. JCI Insight. 2017 Jul 20;2(14). pii: 93652. doi: 10.1172/jci.insight.93652. [Epub ahead of print]

 

Seliger B. Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors. Cytokine Growth Factor Rev. 2017 Jul 13. pii: S1359-6101(17)30113-2. doi: 10.1016/j.cytogfr.2017.07.001. [Epub ahead of print] Review.

 

Friedrich M, Pracht K, Mashreghi MF, Jäck HM, Radbruch A, Seliger B. The role of the miR-148/-152 family in physiology and disease. Eur J Immunol. 2017 Sep 7. doi: 10.1002/eji.201747132. [Epub ahead of print]

 

 

Subbarayan K, Leisz S, Wickenhauser C, Bethmann D, Massa C, Steven A, Seliger B. Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. OncoImmunology 2017. doi: 10.1080/2162402X.2017.1373233

 

 

Steven A, Leisz S, Wickenhauser C, Schulz K, Mougiakakos D, Kiessling R, Denkert C,  Seliger B. Linking CREB function with altered metabolism in murine fibroblast-based model cell lines. Oncotarget 2017 8;57. 97439, doi: 10.18632/oncotarget.22135

 

 

Lennicke C, Rahn J, Wickenhauser C, Lichtenfels R, Müller AS, Wessjohann LA, Kipp AP, Seliger B. Loss of epithelium-specific GPx2 results in aberrant cell fate decisions during intestinal differentiation. OncoImmunology 2017. doi: 10.18632/oncotarget.22640